The FDA has currently approved the Artvigil 150 Tablet to treat shift work disorder, narcolepsy, and excessive daytime sleepiness linked to obstructive sleep apnea. Off-label use for the treatment of major depressive disorder, chronic fatigue syndrome, and attention deficit hyperactivity disorder is prevalent. It has been demonstrated to increase air traffic controllers' attentiveness. sleep issues [Since] The USA. FDA has approved modafinil for the treatment of obstructive sleep apnea, narcolepsy, and shift work sleep disorder. The recommended dose of armodafinil for narcolepsy and obstructive sleep apnea is 150 mg or 250 mg administered once daily in the morning. 150 mg of armodafinil is used one hour before work to treat shift work sleep problems. To lessen certain adverse effects, slow dose titration is required.
Praca
Proszę Zaloguj Się lub Rejestracja